Navigation Links
Leeds research points to new therapy for hepatitis C treatment
Date:12/8/2008

Combination therapies similar to those used for HIV patients may be the best way of treating hepatitis C virus (HCV), say researchers from the University of Leeds.

A study of a protein called p7, has revealed that differences in the genetic coding of the protein between virus strains - known as genotypes - alter the sensitivity of the virus to drugs that block its function.

The p7 protein assists the spread of HCV around the body and is a promising target for new drug treatments for the virus. Its role was discovered in 2003 by Dr Steve Griffin with Professors Mark Harris and Dave Rowlands of the University's Faculty of Biological Sciences. In laboratory tests their latest research shows that inhibiting p7 with drugs can prevent the spread of HCV..

"One of the challenges in finding treatments for viruses is their ability to constantly change their genetic makeup," says Professor Harris. "Our research shows there can't be a one-size-fits-all approach to treating HCV with p7 inhibitors in the future. We believe combination treatments will work much more efficiently, as they take into account the variability of the p7 protein."

Approximately 180 million people worldwide are infected by HCV, which causes inflammation of the liver and can lead to liver failure or liver cancer. Spread by contact with infected blood or other bodily fluids, there is no vaccine against the disease which is largely asymptomatic in its early stages. The disease is currently treated with broad spectrum, non-specific anti-viral drugs.

Dr Griffin and Prof. Harris examined the response of HCV to a panel of compounds including the well known anti-viral drug, rimantadine, which targets a similar protein in the flu virus. They found that the drug's effectiveness was altered depending on the genetic makeup of the p7 protein.

"We 'borrowed' rimantadine to test its effects because p7 behaves similarly to a protein found in the flu virus,
'/>"/>

Contact: Clare Elsley
clare@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert

Page: 1 2

Related biology news :

1. Properties of unusual virus revealed in research
2. U of Minnesota researcher finds link between aggression, status and sex
3. Researchers study virus with unusual properties
4. Dune and dirty: Hurricane teaches lessons through ecosystem research
5. Key to curing obesity may lie in worms that destroy their own fat: McGill researchers
6. Massague honored with inaugural AACR Distinguished Leadership Award in Breast Cancer Research
7. Men are red, women are green, Brown researcher finds
8. UC Davis researchers exploring gene therapy to fight AIDS
9. Researchers solve piece of large-scale gene silencing mystery
10. GEN reports growing focus on PI3-kinase pathway in cancer research
11. A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... of research shows an association between TV viewing and ... a new Cornell University study points out that not ... people to eat twice as much as other programs! ... while snacking your mouth will see more action too!" ... article just published in the Journal of the ...
(Date:9/1/2014)... that corals whose calcium-carbonate skeletons form the ... that rely entirely on ocean currents to deliver ... now scientists at MIT and the Weizmann Institute ... they are far from passive, engineering their environment ... enhance their ability to exchange nutrients and dissolved ...
(Date:9/1/2014)... the alteration of a single nucleotidethe basic building block of DNAcould ... disability. The study appears in The Journal of Cell ... by a defect in a gene on the X chromosome called ... 230 women and 1 in 360 men carry a so-called premutation, ... the FMR1 gene is slightly longer than normal. These ...
Breaking Biology News(10 mins):Can action movies make you fat? 2Nature's tiny engineers 2Nature's tiny engineers 3A nucleotide change could initiate fragile X syndrome 2
... becomes, common ailments like fungal infections can outrun the ... immune systems (like premature babies, AIDS victims or those ... contracting a fungal infection can be deadly. Now ... sea to collect unique chemicals drugs of the ...
... The National Space Biomedical Research Institute (NSBRI) ... Medical Center as one of four young investigators ... Program. Trani is a postdoctoral fellow in ... Department of Biochemistry and Molecular & Cellular Biology. ...
... genotyping technologies offer new opportunities to explore how ... the challenge of analyzing huge amounts of genetic ... at the Lausanne Branch of the international Ludwig ... of Bioinformatics (SIB) and the University Hospital of ...
Cached Biology News:An underwater drugstore? 2GUMC young scientist selected postdoc Fellow at National Space Biomedical Research Institute 2New tool for genome-wide association studies 2
(Date:9/2/2014)... yet often overlooked factor in the medical application ... of aggregation on both radiofrequency heating and magnetic ... nanoparticles (IONPs), including detailed analysis of the aggregate ... shown to produce significant reductions in both heating ... method to quantify and correlate these effects for ...
(Date:9/2/2014)... , September 2, 2014 ... on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: ... Growth by 2019" the global membrane technology market for pharmaceutical, biopharma ... in 2014 and is expected to grow at a ... an estimated value of USD 10,886.0 million in 2019. ...
(Date:9/2/2014)... Sept. 2, 2014 Orexigen Therapeutics, Inc. (Nasdaq: ... Patent and Trademark Office (PTO) has issued a patent ... for weight loss. NB32 is a fixed-dose combination of ... U.S. Patent No. 8,815,889 claims methods for treating insulin ... patent expires in 2024. If NB32 is approved for ...
(Date:9/2/2014)... NC and Rocky Mount, NC (PRWEB) September 02, 2014 ... announced today the establishment of its 11th clinical research ... PMG Research has assumed ownership and operation of the ... Rocky Mount, NC, further expanding PMG’s presence in eastern ... an additional 130,000 patients. For the patients in Rocky ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3
... with Third FDA Market Clearance Since ... ... Corp.,(Nasdaq: ESMC ) today announced that it has received 510(k) ... VascuView(TM),Visual Ultrasound System for use with assisted vascular access. Its,subsidiary, Escalon ...
... with the, Nikon Ti Inverted Microscope System to Provide Advanced ... ... Performance, MELVILLE, N.Y., Jan. 29 Nikon Instruments, Inc., ... scanning systems, which seamlessly integrates with the new Ti-E,research inverted ...
... Pre-Clinical Studies to Commence for Neurological Diseases ... Cryo-Cell International,Inc. (OTC Bulletin Board: CCEL) ("Cryo-Cell" ... most established family cord blood banks, today ... development agreement with Saneron CCEL,Therapeutics, Inc. ("Saneron") ...
Cached Biology Technology:Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 2Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 3Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 4Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series 2Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series 3Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series 4Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc. 2Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc. 3Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc. 4
... Vector is a derivative of the pAcHLT-A Vector ... fluorescent protein (BFP), followed by a 6xHis tag ... expressed as BFP-6xHis fusion proteins when cloned into ... Stu I, Sac I, Not I, Pst I, ...
Mouse monoclonal antibody to ALAS2 - aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia)...
Mouse polyclonal antibody to GRID2 - glutamate receptor, ionotropic, delta 2...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Biology Products: